High Dose Ascorbic Acid (HDAA) in Patients With Plasma Cell Disorders

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
High Dose Ascorbic Acid (HDAA) in Patients With Plasma Cell Disorders	Neoplasms by Histologic Type, neoplasm, plasma cell neoplasm	Recruiting	Phase 1	2026-06-04		NCT06313502

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
University of Arkansas	76
University of Iowa	102

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
University of Arkansas for Medical Sciences	Little Rock	United States	218

Clinical trials